Standard
Thinking in Action, Re-thinking Life : Philosophical Dialogues with Cancer Survivors using the Socratic Method. / Knox, Jeanette Bresson Ladegaard.
In:
Psycho-Oncology, Vol. 25, No. Supplement S3, 92, 10.2016, p. 31-31.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Knox, JBL 2016, '
Thinking in Action, Re-thinking Life: Philosophical Dialogues with Cancer Survivors using the Socratic Method',
Psycho-Oncology, vol. 25, no. Supplement S3, 92, pp. 31-31.
https://doi.org/10.1002/pon.4272
APA
Knox, J. B. L. (2016).
Thinking in Action, Re-thinking Life: Philosophical Dialogues with Cancer Survivors using the Socratic Method.
Psycho-Oncology,
25(Supplement S3), 31-31. [92].
https://doi.org/10.1002/pon.4272
Vancouver
Knox JBL.
Thinking in Action, Re-thinking Life: Philosophical Dialogues with Cancer Survivors using the Socratic Method.
Psycho-Oncology. 2016 Oct;25(Supplement S3):31-31. 92.
https://doi.org/10.1002/pon.4272
Author
Knox, Jeanette Bresson Ladegaard. / Thinking in Action, Re-thinking Life : Philosophical Dialogues with Cancer Survivors using the Socratic Method. In: Psycho-Oncology. 2016 ; Vol. 25, No. Supplement S3. pp. 31-31.
Bibtex
@article{ad53fe1597b54900bb9b002204acb310,
title = "Thinking in Action, Re-thinking Life: Philosophical Dialogues with Cancer Survivors using the Socratic Method",
author = "Knox, {Jeanette Bresson Ladegaard}",
note = "92, ",
year = "2016",
month = oct,
doi = "10.1002/pon.4272",
language = "English",
volume = "25",
pages = "31--31",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "JohnWiley & Sons Ltd",
number = "Supplement S3",
}
RIS
TY - ABST
T1 - Thinking in Action, Re-thinking Life
T2 - Philosophical Dialogues with Cancer Survivors using the Socratic Method
AU - Knox, Jeanette Bresson Ladegaard
N1 - 92,
PY - 2016/10
Y1 - 2016/10
U2 - 10.1002/pon.4272
DO - 10.1002/pon.4272
M3 - Conference abstract in journal
C2 - 27739605
VL - 25
SP - 31
EP - 31
JO - Psycho-Oncology
JF - Psycho-Oncology
SN - 1057-9249
IS - Supplement S3
M1 - 92
ER -
